J.Safra Asset Management Corp Grows Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

J.Safra Asset Management Corp raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 461.6% during the fourth quarter, HoldingsChannel reports. The firm owned 292,502 shares of the exchange traded fund’s stock after buying an additional 240,415 shares during the quarter. SPDR S&P Biotech ETF comprises 2.1% of J.Safra Asset Management Corp’s holdings, making the stock its 14th largest position. J.Safra Asset Management Corp’s holdings in SPDR S&P Biotech ETF were worth $26,293,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after purchasing an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd purchased a new position in SPDR S&P Biotech ETF during the third quarter worth $141,284,000. Proficio Capital Partners LLC increased its position in SPDR S&P Biotech ETF by 16,156.1% during the fourth quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock valued at $82,615,000 after acquiring an additional 911,686 shares during the last quarter. Mirae Asset Securities USA Inc. raised its stake in shares of SPDR S&P Biotech ETF by 50.0% in the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after acquiring an additional 300,000 shares during the period. Finally, Assetmark Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 72,653.0% in the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after acquiring an additional 588,489 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 0.6 %

XBI stock opened at $86.13 on Wednesday. The stock has a market cap of $5.68 billion, a PE ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The company has a 50-day moving average price of $90.76 and a 200 day moving average price of $95.58.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.